Table 6.
LH Prevalence in Patients with T1DM
| Author (Year) | Male | Female | All | P-value | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Present No (% Among Patients with LH) | Absent No (% Among Patients Without LH) | LH Prevalence (%) | Present No (% Among Patients with LH) | Absent No (% Among Patients Without LH) | LH Prevalence (%) | Present No (% Among Patients with LH) | Absent No (% Among Patients Without LH) | Overall | LH Prevalence (%) | ||
| Lin et al (2021)19 | 48(57.83%) | 22(59.46%) | 68.57% | 35(42.17%) | 15(40.54%) | 70.00% | 83(69.17%) | 37(30.83%) | 120 | 69.17% | 0.8673 |
| Tsadik et al (2018)24 | 53(51.46%) | 33(45.21%) | 61.63% | 50(48.54%) | 40(54.79%) | 55.56% | 103(58.52%) | 73(41.48%) | 176 | 58.52% | 0.4137 |
| Hernar et al (2017)17 | 64(57.66%) | 47(45.19%) | 57.66% | 47(42.34%) | 57(54.81%) | 45.19% | 111(51.63%) | 104(48.37%) | 215 | 51.63% | 0.0767 |
| Al Hayek et al (2016)25 | 43(51.81%) | 47(51.65%) | 47.78% | 40(48.19%) | 44(48.35%) | 47.62% | 83(47.70%) | 91(52.30%) | 174 | 47.70% | 0.9833 |
| Sawatkar et al (2014)26 | 119(58.05%) | 153(51.86%) | 43.75% | 86(41.95%) | 142(48.14%) | 37.72% | 205(41.00%) | 295(59.00%) | 500 | 41.00% | 0.1721 |
| Total | 327(55.90%) | 302(50.33%) | 51.99% | 258(44.10%) | 298(49.67%) | 46.40% | 103(58.53%) | 73(41.49%) | 1185 | 49.37% | 0.055 |